Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-02-03 @ 2:09 AM
Study NCT ID:
NCT03854994
Status:
UNKNOWN
Last Update Posted:
2019-02-26
First Post:
2019-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia
Sponsor:
Yan'an Affiliated Hospital of Kunming Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-20
First Submit QC Date:
None
Study First Post Date:
2019-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-25
Last Update Post Date:
2019-02-26
Last Update Post Date Type:
ACTUAL